Deferred Tax Assets, Net of Valuation Allowance in USD of Boundless Bio, Inc. from Q4 2023 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Boundless Bio, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q4 2023 to Q4 2024.
- Boundless Bio, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $13.3M, a 1844% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)